loadpatents
name:-0.0693199634552
name:-0.022849082946777
name:-0.0033650398254395
KAVANAUGH; W. Michael Patent Filings

KAVANAUGH; W. Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for KAVANAUGH; W. Michael.The latest application filed is for "activatable anti-cd166 antibodies and methods of use thereof".

Company Profile
3.23.33
  • KAVANAUGH; W. Michael - South San Francisco CA
  • KAVANAUGH; W. Michael - Orinda CA
  • Kavanaugh; W. Michael - Mill Valley CA
  • Kavanaugh; W. Michael - Marin CA
  • Kavanaugh; W. Michael - Oakland CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Activatable Anti-cd166 Antibodies And Methods Of Use Thereof
App 20220023439 - CARMAN; Lori ;   et al.
2022-01-27
Activatable Anti-cd166 Antibodies And Methods Of Use Thereof
App 20210100913 - CARMAN; Lori ;   et al.
2021-04-08
Systems And Methods For Quantitative Pharmacological Modeling Of Activatable Antibody Species In Mammalian Subjects
App 20210020264 - Stroh; Mark Anthony ;   et al.
2021-01-21
Activatable Anti-cd166 Antibodies And Methods Of Use Thereof
App 20190117789 - CARMAN; LORI ;   et al.
2019-04-25
Angiogenically Effective Unit Dose Of FGF And Method Of Administering
App 20180221446 - Whitehouse; Martha J. ;   et al.
2018-08-09
Slamf1 Antagonists And Uses Thereof
App 20180016555 - Borges; Luis ;   et al.
2018-01-18
Angiogenically Effective Unit Dose Of Fgf And Method Of Administering
App 20160120943 - Whitehouse; Martha J. ;   et al.
2016-05-05
Method of treatment of cancers characterized by ligand-dependent activating mutations in FGFR2 with FGFR1 ECD proteins
Grant 9,169,313 - Harding , et al. October 27, 2
2015-10-27
Method of treating coronary artery disease by administering FGF-9
Grant 9,149,507 - Whitehouse , et al. October 6, 2
2015-10-06
Hair Growth Methods Using Fgfr3 Extracellular Domains
App 20140274898 - Brennan; Thomas ;   et al.
2014-09-18
Use Of Fgfr1 Extra Cellular Domain Proteins To Treat Cancers Characterized By Ligand-dependent Activating Mutations In Fgfr2
App 20140227263 - Harding; Thomas ;   et al.
2014-08-14
Angiogenically Effective Unit Dose Of Fgf And Method Of Administering
App 20140142038 - Whitehouse; Martha J. ;   et al.
2014-05-22
Hair growth methods using FGFR3 extracellular domains
Grant 8,685,931 - Brennan , et al. April 1, 2
2014-04-01
Method of treating coronary artery disease by administering FGF-5
Grant 8,618,052 - Whitehouse , et al. December 31, 2
2013-12-31
Use of FGFR1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in FGFR2
Grant 8,614,183 - Harding , et al. December 24, 2
2013-12-24
Method of promoting hair growth using FGFR4 extracellular domains
Grant 8,445,445 - Brennan , et al. May 21, 2
2013-05-21
Hair Growth Methods Using Fgfr3 Extracellular Domins
App 20130058928 - Brennan; Thomas ;   et al.
2013-03-07
Hair Growth Methods Using Fgfr4 Extracellular Domains
App 20120183541 - Brennan; Thomas ;   et al.
2012-07-19
Angiogenically Effective Unit Dose Of Fgf And Method Of Administering
App 20120165245 - Whitehouse; Martha J. ;   et al.
2012-06-28
Method for inducing angiogenesis in a heart of a patient
Grant 8,178,493 - Hung , et al. May 15, 2
2012-05-15
Angiogenically effective unit dose of FGF and method of administering
Grant 7,858,584 - Whitehouse , et al. December 28, 2
2010-12-28
EGFH2 genes and gene products
Grant 7,705,117 - Kavanaugh , et al. April 27, 2
2010-04-27
Dose Of An Angiogenic Factor And Method Of Administering To Improve Myocardial Blood Flow
App 20090221504 - Hung; David T. ;   et al.
2009-09-03
Angiogenically Effective Unit Dose Of Fgf And Method Of Administering
App 20090170776 - Whitehouse; Martha J. ;   et al.
2009-07-02
Method for inducing angiogenesis or vascular perfusion in the myocardium comprising administering FGF-2
Grant 7,531,511 - Hung , et al. May 12, 2
2009-05-12
Method of treating coronary artery disease by administering FGF-4
Grant 7,511,019 - Whitehouse , et al. March 31, 2
2009-03-31
Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
Grant 7,476,506 - Schleyer , et al. January 13, 2
2009-01-13
KGF polypeptide compositions
App 20080200378 - Gospodarowicz; Denis J. ;   et al.
2008-08-21
Anti-Cancer and Anti-Infectious Disease Compositions and Methods for Using Same
App 20080159957 - Kavanaugh; W Michael ;   et al.
2008-07-03
Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
App 20080008711 - Schleyer; Siew C. ;   et al.
2008-01-10
EGFH2 genes and gene products
App 20080004428 - Kavanaugh; W. Michael ;   et al.
2008-01-03
Antibodies to EGFH2 polypeptides
Grant 7,276,587 - Kavanaugh , et al. October 2, 2
2007-10-02
KGF polypeptide compositions
Grant 7,265,089 - Gospodarowicz , et al. September 4, 2
2007-09-04
Human FGF-21 polypeptides
Grant 7,259,248 - Itoh , et al. August 21, 2
2007-08-21
Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
App 20070148691 - Schleyer; Siew C. ;   et al.
2007-06-28
Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
Grant 7,198,899 - Schleyer , et al. April 3, 2
2007-04-03
Human FGF-23 gene and gene expression products
App 20060281679 - Itoh; Nobuyuki ;   et al.
2006-12-14
Angiogenically effective unit dose fo FGF and method of adminstering
App 20060025343 - Whitehouse; Martha J. ;   et al.
2006-02-02
Dose of an angiogenic factor and method of administering to improve myocardial blood flow
App 20060009390 - Hung; David T. ;   et al.
2006-01-12
EGFH2 genes and gene products
App 20050202006 - Kavanaugh, W. Michael ;   et al.
2005-09-15
EGFH2 genes and gene products
Grant 6,825,333 - Kavanaugh , et al. November 30, 2
2004-11-30
PI 3-kinase fusion mutants and uses thereof
App 20040091898 - Klippel, Anke ;   et al.
2004-05-13
Fibroblast growth factor
App 20040063910 - Kavanaugh, W. Michael ;   et al.
2004-04-01
Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
App 20040005622 - Schleyer, Siew C. ;   et al.
2004-01-08
Fibroblast growth factor receptor-immunoglobulin fusion
Grant 6,656,728 - Kavanaugh , et al. December 2, 2
2003-12-02
Dose of an angiogenic factor and method of administering to improve myocardial blood flow
App 20030171294 - Hung, David T. ;   et al.
2003-09-11
PI 3-kinase fusion mutants and uses thereof
Grant 6,613,956 - Klippel , et al. September 2, 2
2003-09-02
KGF polypeptide compositions
App 20030109439 - Gospodarowicz, Denis J. ;   et al.
2003-06-12
Human FGF-23 gene and gene expression products
App 20030105302 - Itoh, Nobuyuki ;   et al.
2003-06-05
Human FGF-21 gene and gene expression products
App 20020164713 - Itoh, Nobuyuki ;   et al.
2002-11-07
Human FGF-23 gene and gene expression products
App 20020082205 - Itoh, Nobuyuki ;   et al.
2002-06-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed